Health September 23, 2021 Tec School of Medicine hosts international conference The School of Medicine and Health Sciences hosted the annual Universitas 21 Health Sciences Group conference.
Research September 03, 2021 Researchers patent plant-based therapy for an eye anomaly Researchers from the Tec’s School of Medicine have obtained a patent after researching a plant extract for an eye disease called pterygium.
Health July 13, 2021 Infectious disease specialist talks about COVID-19 vaccinations Reynaldo Lara, an infectious disease specialist at TecSalud, answers questions about whether it’s a good idea for people who’ve been vaccinated to take a different dose from another laboratory.
Health July 05, 2021 New COVID variants: what you should know New variants of the virus that causes COVID-19 make it spread easier and faster. A TecSalud expert answers questions about these variants.
Health June 25, 2021 The doctor who created an innovative health system in Mexico Dr. Guillermo Torre, researcher, clinician, and surgeon, has helped establish an innovative system at TecSalud, Tec de Monterrey’s health system.
Health May 12, 2021 Tec graduate researcher discovers new lung cell and wins US grant Lisandra Vila Ellis, who holds a medical degree from the Tec de Monterrey School of Medicine, has won a United States research project grant after discovering a new lung cell.
Research May 11, 2021 TecSalud will develop a protocol for cell therapy against COVID-19 TecSalud and NovocellBio signed a collaboration agreement to start the NK (natural killer) immune cell culture protocol.
Health May 03, 2021 Mexican CureVac vaccine studies move ahead with TecSalud TecSalud demonstrates research leadership by participating in the German CureVac COVID-19 vaccine clinical trial.
Health March 02, 2021 Advice from experts on double masking against COVID-19 Health experts explain why wearing two face masks, or a single mask with a tight fit to the face, offers greater protection against COVID-19.
Health February 17, 2021 TecSalud begins Phase 3 trials of German CureVac vaccine in Mexico TecSalud has started administering the vaccine candidate from German pharmaceutical company CureVac for its Phase 3 clinical trials.
